Coriell Using IBM for Biosample Management | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – The Coriell Institute for Medical Research has tapped IBM to develop a layered solution to protect and manage its biosamples and the vast amounts of genomic data generated in its personalized medicine research projects, IBM said today.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Canada begins its search for a chief government science advisor, Nature News reports.

A company is using facial recognition tools to identify genetic disorders from pictures, Technology Review reports.

In PNAS this week: genes involved in histone deacetylation in Arabidopsis, effects of pathogenic presenilin-1 mutations, and more.

After a study finds DNA from antibiotic-resistant bacteria in Beijing smog, residents there worry, according to the New York Times.